Society for Male Reproduction and Urology Minisymposium - Detecting and Treating Male Factor Infertility

Presenters

Needs Assessment and Description
Detecting and treating male factor infertility is a critical part of a couple’s infertility workup. This live course for healthcare professionals involved in treatment of male-factor infertility will discuss the prevalence of male factor among infertile couples and will delineate the state-of-the-art interventions for this indication. Current treatment approaches for azoospermic men will be described along with the newest information on the different elements of the male gamete that allow evaluation of its embryo developmental competence.

Learning Objectives
At the conclusion of this session, participants should be able to: 

1. Discuss the extent of male infertility and the current treatment options for the use of ejaculated and surgicallyretrieved spermatozoa. 
2. Identify the current knowledge on the various components of the male gamete and their impact on assisted reproductive technology (ART) treatment.

ACGME Competency
Patient Care

TEST QUESTION:
After participating in this session, in my practice, once the indications for intra-cytoplasmic sperm injection (ICSI) have been established for an infertile couple, I will inform the patient that: 

1. The risk to the offspring with in vitro fertilization (IVF)/ ICSI has not been proven to be greater than the risk with standard IVF. 
2. ICSI is a highly experimental procedure and should only be used in the “worst-case scenario” since very limited data is available about offspring health. 
3. Standard in vitro insemination generates consistently higher fertilization rates than ICSI with a better chance of achieving a clinical pregnancy. 
4. ICSI should only be used for azoospermic men. 
5. Not applicable to my area of practice.